Tamoxifen treatment
Tamoxifen treatment was done as described in (S2) . Tamoxifen (SIGMA) was dissolved in pre-warmed corn oil (SIGMA) to make a 20 mg /ml solution and stored at 4°C. To obtain maximal Cre-ERT2 recombinaison efficiency at later embryonic stages, we have administrated a dose of 10 mg at 12.5 dpc and at each following 12 hours, for three times.
Specimens were collected at 14.5 dpc.
Histochemical staining
For cytochrome oxydase (CO) histochemical staining, animals at postnatal stages were perfused with 4 % paraformaldehyde (PFA), before dissection of the brain. 40 µm cryostat sections were cut in the coronal plane to visualise barrelettes or barreloids at brainstem or thalamus levels, respectively. The CO staining was performed according to the procedure described in (S7) . The sections were incubated in a solution consisting of 4 g sucrose, 50 mg diaminobenzidine, and 40 mg cytochrome C in 100 ml PBS at 37°C in the dark overnight. The sections were rinsed in PBS, mounted onto slides, coverslipped with glycerol, and examined under a microscope.
For alkaline phosphatase (AP) staining, brain sections prepared the same way as for CO histochemistry were incubated in PBS at 65°C during 90 min to inactivate the endogenous AP. After the inactivation, sections were rised in a solution of NTMT (NaCl 5M, Tris HCL 1M (pH 9.5), MgCl2 1M, Levamisol 62.5x and Tween 20 50%). Finally, the sections were overlayed in a solution consisting of NTMT with NBT and BCIP. The sections were rinsed first in PBS and next in EtOH 100%, mounted onto slides.
In situ hybridisation
In situ hybridisation was performed as described in (2). Briefly, brains were dissected, fixed in 4% PFA overnight at 4°C, put in sucrose 20%, embedded in Shandon Cryomatrix (Thermo Electron Corporation), and frozen at -80°C. 20 µm cryostat sections were cut in the coronal or sagittal planes.
Retrograde dextran labeling
Rhodamine-or Alexa488-conjugated dextrans (Molecular Probes, Eugene, Oregon) were employed for retrograde labelling of trigeminal nerve branches in mouse embryos according to (S8) with the following modifications: ophthalmic (V1) and maxillary (V2) branches were labelled by applying dextran crystals by applying crystals in a surgically created pouch in the respective sensory field, namely the periorbital region for V1 and under the whisker pad for V2, while the mandibular (V3) branch was labelled by applying crystals in the sectioned mandibular nerve at the spix foramen. The embryos were incubated as described in (S8), fixed in 4% paraformaldehyde in 0.1 M phosphate-buffered saline and embedded into 3% agarose. 100 µm vibratome sections were collected and analysed under confocal microscope (Leica).
TUNEL assay
Brains were fixed overnight in freshly prepared 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, cryoprotected in 20% sucrose in 0.1 M phosphate buffer, pH 7.4, and embedded in Shandon Cryomatrix (Thermo Electron Corporation). Coronal sections, 15 µm thick, were mounted on Superfrost glass slides. Apoptotic cells were detected by an insitu nick-end labeling procedure using a commercial kit (Roche).
Supplementary Figure Legends
Figure S1 Hoxa2 and rhombomere dependent establishment of somatotopic organisation in the mouse trigeminal sensory system Long-term mapping of the rhombomeric origin of the PrV nucleus in the mouse revealed that the progeny of r3 (r3p) uniquely contributes to the portion that segregates into whisker-related neuronal patterns at postnatal stages, whereas the lower jaw-lip map is entirely contributed by the r2 derived progeny (r2p). Moreover, topographic mapping of axonal terminations from PrV neurons into the target VPM thalamus was also rhombomere-specific. The drawing additionally summarizes the distinct spatiotemporal roles of Hoxa2 in the development of the trigeminal somatosensory circuit. At early developmental stages (i.e. before E12.5), Hoxa2 expression is required in the r2 neuroepithelium to stop the trigeminal nerve near the entry point in the rostral hindbrain. In the absence of Hoxa2 in r2, the trigeminal nerve projects ectopically to the cerebellum. At later stages (i.e. after E12.5), Hoxa2 expression in r3-derived PrV: i) promotes maxillary afferent arborisation; and ii) it is involved in the topographic mapping of PrV axonal connections to VPM, with loss of Hoxa2 expression resulting in somatotopic changes in the circuit and absence of whisker-related patterns in the postnatal brain. 
